Cover Image

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate

Saved in:

Bibliographic Details
Main Authors:	Patrick F (Author), Kassoumeri L (Author), Beard L (Author), Hamaoui RHB (Author), Varsani H (Author), Moncrieffe H (Author), Ursu S (Author), Wedderburn LR (Author)
Format:	Book
Published:	BMC, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
by: Roth J, et al.
Published: (2011)

Methotrexate in childhood arthritis: effects on gene expression
by: Moncrieffe H, et al.
Published: (2008)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani SP, et al.
Published: (2008)

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
by: Hirani SP, et al.
Published: (2008)

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
by: Livermore P, et al.
Published: (2008)

Determing an "autoimmune" phenotype in systemic JIA
by: Haas JP, et al.
Published: (2011)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
by: Meredyth G. Ll Wilkinson, et al.
Published: (2021)

Juvenile dermatomyositis (JDM) sine myositis
by: Schulz A, et al.
Published: (2011)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008)

Myeloid cells which secrete S100 proteins in juvenile dermatomyositis may contribute to disease activity
by: Varsani H, et al.
Published: (2008)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
by: Luz Contreras, et al.
Published: (2011)

CD39: a regulatory role in childhood arthritis
by: Moncrieffe H, et al.
Published: (2008)

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)
by: Rabheh Abdul-Aziz, et al.
Published: (2017)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
by: Smith S, et al.
Published: (2008)

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource
by: Saskia Lawson-Tovey, et al.
Published: (2023)

Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial
by: Foedvari I, et al.
Published: (2008)

Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS)
by: Hyrich KL, et al.
Published: (2008)

Jia Zhangke on Jia Zhangke
by: Berry, Michael
Published: (2022)

Jia Zhangke on Jia Zhangke
by: Berry, Michael
Published: (2022)

Case of juvenile dermatomyositis (JDM), thrombotic thrombocytopenic purpura (TTP), and Purtscher retinopathy
by: Goldzweig Ofra, et al.
Published: (2012)

Race is a risk factor for calcinosis in patients with JDM - early results from the CARRAnet registry study
by: Hoeltzel Mark F, et al.
Published: (2012)

Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)
by: Alexander Gebreamlak, et al.
Published: (2023)

Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland
by: Beard L, et al.
Published: (2011)

In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study
by: Roberta Naddei, et al.
Published: (2022)

Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial
by: Reza Shiari, et al.
Published: (2024)

Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children
by: Xinning Wang, et al.
Published: (2021)

THE MAIN MARKERS OF AUTOIMMUNE RHEUMATIC DISEASES AND THEIR INTERPRETATION
by: A. S. Burlakova, et al.
Published: (2016)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
by: Ferrari C, et al.
Published: (2008)

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
by: Nistala Kiran, et al.
Published: (2011)

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
by: Nistala Kiran, et al.
Published: (2011)

Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA
by: Justyna Roszkiewicz, et al.
Published: (2020)

Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers.
by: Gebeyaw G Mekonnen, et al.
Published: (2022)

Assessment of proliferation and apoptosis markers in patients with autoimmune thyroiditis
by: M. I. Sheremet, et al.
Published: (2016)

Assessment of proliferation and apoptosis markers in patients with autoimmune thyroiditis
by: M. I. Sheremet, et al.
Published: (2016)

Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry
by: Angela Nyangore Migowa, et al.
Published: (2024)

Temporomandibular joint arthritis in patients with non-JIA childhood arthritis
by: Cron Randy Q, et al.
Published: (2012)

Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline
by: Margarita Ganeva, et al.
Published: (2021)

Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study
by: Baghdadi LR, et al.
Published: (2018)

Characterisation of colorectal cancer by hierarchical clustering analyses for five stroma‐related markers
by: Sunao Ito, et al.
Published: (2024)

Features of the course and treatment of JIA-associated uveitis
by: M.V. Panchenko, et al.
Published: (2019)